logo

Brainstorm Cell Therapeutics, Inc. (BCLI) Stock: Uncovering 52-Week Market Trends

OPEN Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Brainstorm Cell Therapeutics, Inc.’s current trading price is -78.92% away from its 52-week high, while its distance from the 52-week low is 184.78%. The stock’s price range over this period has fluctuated between $0.13 and $1.81. The company, operating within the financial sector, had a trading volume of approximately 0.87 million for the day, which was noticeably higher than the average daily share volume of 0.59 million over the last 3 months.

Brainstorm Cell Therapeutics, Inc. experienced a rather shaky stock market performance. The highest value in the past year was recorded at $1.81 on 08/29/23 and the lowest value was $0.13 on 10/31/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Brainstorm Cell Therapeutics, Inc. (BCLI) has experienced a quarterly decline of -26.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 30.42M and boasts a workforce of 29 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4464, with a change in price of -0.2784. Similarly, Brainstorm Cell Therapeutics, Inc. recorded 712,610 in trading volume during the last 100 days, posting a change of -42.18%.

BCLI Stock Stochastic Average

Today, Brainstorm Cell Therapeutics, Inc.’s raw stochastic average for the past 50 days stands at 53.25%, indicating a decline from the raw stochastic average of the last 20 days, which was 90.69%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 76.46% and 65.18% respectively.

BCLI Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 39.78%. However, over the past six months, we’ve seen a weaker performance of 2.11%. The price of BCLI fallen by 10.19% over the last 30 days. And in the last five days, it has surged by 29.80%.

Most Popular